FDA Adverse Event Death Summary report: N

SIR-SPHERES MICROSPHERES

MDR report key: 1368827 · Received January 22, 2009

Report

Report Number
9710358-2009-00001
Event Type
Death
Date Received
January 22, 2009
Report Date
January 20, 2009
Manufacturer
SIRTEX MEDICAL LIMITED
Product Code
KXK
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
NJ, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

PT WAS POLYCHEMOTHERAPY RESISTANT AND TREATED AS SALVAGE THERAPY WHERE THERE IS USUALLY AN EXTREMELY NARROW WINDOW OF NORMAL LIVER. RAISED BILIRUBIN AT 4 WEEKS POST SIRT IS CONSISTENT WITH RADIATION HEPATITIS/RADIATION-INDUCED LIVER DISEASE. WE WILL FOLLOW UP FOR DISCUSSIONS TO REVIEW: DOSIMETRY IN POLYCHEMOTHERAPY-RESISTANT MCRC. MGMT OF RADIATION HEPATITIS/RADIATION INDUCED LIVER DISEASE BASED ON CURRENT LITERATURE. THERE IS NO EVIDENCE OF PRODUCT MALFUNCTION - THE BATCH MET ALL RELEASE CRITERIA. SEE SCANNED PAGE.

Description of Event or Problem · 1

DEATH RELATED TO MUTI-ORGAN SYSTEM FAILURE COMPLICATING SEPSIS. ORIGINAL DIAGNOSIS, 2004, LIVER METASTASES. 2004, TREATMENTS INCLUDED: 5 FU, AVASTIN, ERBITUX, IRINOTECAN. ECOG 0. NO UNDERLYING LIVER DISEASE. BSA 1.92 SHUNT 6%. BASELINE LFT. TI BILI 1.5. ERBITUX DISCONTINUED 2 WEEKS PRIOR TO TREATMENT. SIR-SPHERES TREATMENT WHOLE LIVER TREATMENT DATE 2008. LIVER VOL 2178. PRESCRIBED ACT 1.9 GBQ. DELIVERED 1.9 GBQ. ERBITUX REINITIATED AFTER 2 WKS AT ONCOLOGIST. FAILURE TO RESPOND TO MEDICAL TREATMENT OF SEPSIS LED TO MULTIORGAN SYSTEM FAILURE AND DEATH FROM COMPLICATIONS OF SEPSIS ABOUT 3 MONTHS LATER. WHILE THE PATIENT'S RADIATION INDUCED, LIVER DISEASE APPEARED TO RESPOND TO STEROID THERAPY. IT IS FELT THAT THE STEROID THERAPY CONTRIBUTED TO THE PATIENT'S SEPSIS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 SIR-SPHERES MICROSPHERES YTTRIUM 90 RESIN MICROSPHERES KXK SIRTEX MEDICAL LIMITED Y001 115698-09 OR -09

Patients

Seq Age Sex Outcome Treatment
1 63 YR Death